Medline (FRA:L10) Long-Term Debt: €10,892 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L10 Medline Inc FRA:L10
16 GF Score
Price €29.80
! 3 Warning Signs
View Full Analysis

What is Medline Long-Term Debt?

Medline FRA:L10 +4.20% 16 Long-Term Debt is €10,892 Mil as of Jun. 2026. GuruFocus rates FRA:L10 with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Medline's Long-Term Debt for the quarter that ended in Jun. 2026 was €10,892 Mil.

Medline's quarterly Long-Term Debt increased from Dec. 2025 (€10,661 Mil) to Mar. 2026 (€10,808 Mil) and increased from Mar. 2026 (€10,808 Mil) to Jun. 2026 (€10,892 Mil).

Medline's annual Long-Term Debt increased from Dec. 2023 (€15,077 Mil) to Dec. 2024 (€15,677 Mil) but then declined from Dec. 2024 (€15,677 Mil) to Dec. 2025 (€10,661 Mil).

Medline  (FRA:L10) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medline Long-Term Debt Related Terms

Medline Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medline's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Long-Term Debt Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Long-Term Debt
0.00 15,077.31 15,677.28 10,661.34

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,306.37 14,058.85 10,661.34 10,808.18 10,891.66
FRA:L10
16GF Score
Medline Inc FRA:L10
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €10,892 Mil mean?
Medline (FRA:L10) has a Long-Term Debt of €10,892 Mil as of Jun. 2026.
Is Medline's Long-Term Debt too high?
Medline's current Long-Term Debt is €10,892 Mil. Overall, Medline has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Long-Term Debt compare to RMD and WST?
Medline's Long-Term Debt of €10,892 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medline's current Long-Term Debt is €10,892 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Long-Term Debt of €10,892 Mil. The current Long-Term Debt is €10,892 Mil. Medline's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medline (FRA:L10), the current Long-Term Debt is €10,892 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges MDLN:USA
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
16GF Score

Get the complete analysis for FRA:L10

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.80
Price